Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$209.01 - $232.56 $27,798 - $30,930
-133 Reduced 0.48%
27,548 $6.02 Million
Q4 2023

Jan 12, 2024

SELL
$197.69 - $227.29 $348,527 - $400,712
-1,763 Reduced 5.99%
27,681 $6.29 Million
Q3 2023

Nov 01, 2023

BUY
$201.05 - $221.7 $2.09 Million - $2.31 Million
10,409 Added 54.68%
29,444 $5.92 Million
Q2 2023

Jul 12, 2023

SELL
$211.93 - $241.33 $360,281 - $410,261
-1,700 Reduced 8.2%
19,035 $4.59 Million
Q1 2023

May 11, 2023

BUY
$213.32 - $257.83 $710,568 - $858,831
3,331 Added 19.14%
20,735 $4.76 Million
Q4 2022

Jan 25, 2023

BUY
$203.72 - $248.97 $468,556 - $572,631
2,300 Added 15.23%
17,404 $0
Q3 2022

Oct 19, 2022

SELL
$204.81 - $262.19 $2,867 - $3,670
-14 Reduced 0.09%
15,104 $3.09 Million
Q2 2022

Jul 27, 2022

SELL
$213.86 - $277.87 $444,187 - $577,135
-2,077 Reduced 12.08%
15,118 $3.54 Million
Q1 2022

May 16, 2022

BUY
$259.82 - $298.18 $203,698 - $233,773
784 Added 4.78%
17,195 $4.53 Million
Q4 2021

Feb 14, 2022

BUY
$271.6 - $314.21 $58,665 - $67,869
216 Added 1.33%
16,411 $5.16 Million
Q3 2021

Nov 15, 2021

BUY
$274.82 - $308.34 $142,906 - $160,336
520 Added 3.32%
16,195 $4.56 Million
Q2 2021

Aug 10, 2021

BUY
$251.87 - $278.14 $275,797 - $304,563
1,095 Added 7.51%
15,675 $4.32 Million
Q1 2021

May 14, 2021

BUY
$204.88 - $255.03 $650,494 - $809,720
3,175 Added 27.84%
14,580 $3.72 Million
Q4 2020

Feb 16, 2021

BUY
$186.91 - $214.42 $2.13 Million - $2.45 Million
11,405 New
11,405 $2.32 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $19.9B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Heron Bay Capital Management Portfolio

Follow Heron Bay Capital Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Heron Bay Capital Management, based on Form 13F filings with the SEC.

News

Stay updated on Heron Bay Capital Management with notifications on news.